Meeting Overview - The company will hold its first extraordinary general meeting of shareholders in 2025 on September 8, 2025 [1][2] - The meeting is convened by the board of directors of Xi'an International Medical Investment Co., Ltd. [2] - The meeting complies with relevant laws and regulations, including the Company Law and the rules for listed companies [2] Meeting Details - The on-site meeting will take place at 2:45 PM on September 8, 2025, with online voting available throughout the day [3] - Shareholders can vote either in person or via the internet, but cannot use both methods for the same vote [3] - The record date for shareholders to attend the meeting is September 3, 2025 [3][4] Attendance - All shareholders registered by the record date are entitled to attend the meeting, along with the company's directors, supervisors, and legal advisors [4] - The meeting will be held at Xi'an International Medical Center Hospital [4] Agenda Items - The meeting will include several proposals, with one requiring a special resolution needing approval from over two-thirds of the voting rights present [6] - Only one director will be elected during this meeting, and cumulative voting will not apply [7] Voting Procedures - Shareholders can participate in online voting through the Shenzhen Stock Exchange trading system or internet system [12] - Voting codes and instructions for the proposals will be provided, with all proposals being non-cumulative [14][15] Registration Information - Registration for the meeting can be done in person or via fax or mail for distant shareholders [9] - The registration period is from September 4 to September 5, 2025, with the option to register on the day of the meeting [11] Additional Information - Shareholders are responsible for their own travel and accommodation expenses [18] - Contact information for inquiries is provided, including phone and fax numbers [19]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：000516 证券简称：国际医学 公告编号：2025-041 西安国际医学投资股份有限公司关于召开2025年第一次临时股东会的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 2.召集人：西安国际医学投资股份有限公司董事会。 3.公司第十三届董事会第六次会议审议通过了关于召开公司2025年第一次临时股东会的事项。会议的召 开符合《公司法》《上市公司股东会规则》《股票上市规则》等有关法律法规、规范性文件的规定和 《公司章程》的要求。 4.会议召开时间： 现场会议时间：2025年9月8日（星期一）下午2:45； 网络投票时间：2025年9月8日。 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为： 2025年9月8日的交易时间，即09:15一09:25，09:30一11:30和13:00一15:00；通过深圳证券交易所互联网 系统投票的具体时间为：2025年9月8日09:15一15:00期间任意时间。 5.会议的召开方式：现场表决和网络投票相结合的方式。 本公司于2025年8月22日在《 ...

Meeting Announcement - The company will hold its first extraordinary general meeting of shareholders for 2025 on September 8, 2025, at 2:45 PM [1][2] - The meeting will comply with relevant laws and regulations, including the Company Law and the rules for listed companies [1] Voting Procedures - Shareholders can choose either on-site voting or online voting, but not both [2] - Voting will be conducted through the Shenzhen Stock Exchange trading system and an internet voting platform [1][4] Registration Details - Legal representatives of corporate shareholders must provide identification and proof of their status, while individual shareholders must present their ID and shareholding certificates for registration [3] - Remote shareholders can register via fax or mail [3] Voting Timeline - Online voting will be available on September 8, 2025, from 9:15 AM to 3:00 PM [5][13] - The voting process requires shareholders to authenticate their identity using a digital certificate or investor service password [5][13] Proposals for Voting - All proposals for the meeting are non-cumulative voting proposals, meaning shareholders express their opinions on each proposal individually [5][11] - The total proposal will be considered as a unified vote for all individual proposals [5][11]

证券日报网讯 9月3日晚间，国际医学（000516）发布公告称，公司将于2025年9月8日召开2025年第一 次临时股东会。本次股东会将审议《关于修改〈公司章程〉的议案》等多项议案。 ...

证券代码：000516 证券简称：国际医学 公告编号：2025-041 西安国际医学投资股份有限公司 关于召开2025年第一次临时股东会的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 本公司于 2025 年 8 月 22 日在《证券时报》《中国证券报》《上海证券报》 《证券日报》和巨潮资讯网上发布了《关于召开 2025 年第一次临时股东会的通 知》，定于 2025 年 9 月 8 日召开 2025 年第一次临时股东会。为进一步保护投 资者的合法权益，方便本公司股东行使股东会表决权，现根据相关规定，发布 关于召开公司 2025 年第一次临时股东会的提示性公告如下： 一、会议召开的基本情况 1.股东会届次：本次股东会是 2025 年第一次临时股东会。 2.召集人：西安国际医学投资股份有限公司董事会。 3.公司第十三届董事会第六次会议审议通过了关于召开公司 2025 年第一次 临时股东会的事项。会议的召开符合《公司法》《上市公司股东会规则》《股 票上市规则》等有关法律法规、规范性文件的规定和《公司章程》的要求。 4.会议召开时间： （1）截至 2025 ...

证券日报网讯 9月2日晚间，国际医学发布公告称，控股股东世纪新元于2025年9月1日解除质押38， 230，000股，占其所持股份比例6.21%，占公司总股本比例1.71%。同日，一致行动人申华控股质押 25，310，000股，占其所持股份比例41.84%，占公司总股本比例1.13%。 （文章来源：证券日报） ...

证券代码：000516 证券简称：国际医学 公告编号： | 2025-040 | | | | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 西安国际医学投资股份有限公司 | | | | | | | | | | | | | | 关于控股股东解除质押 | | | | | | | | | | | | | | 及一致行动人进行股份质押的公告 | | | | | | | | | | | | | | 本公司及董事会全体成员保证信息披露的内容的真实、准确、 | | | | | | | | | | | | | | 完整，没有虚假记载、误导性陈述或重大遗漏。 | | | | | | | | | | | | | | 西安国际医学投资股份有限公司（以下简称"公司"）近日接到控 | | | | | | | | | | | | | | 股股东陕西世纪新元商业管理有限公司（以下简称"世纪新元"）及其 | | | | | | | | | | | | | | 一致行动人申华控股集团有限公司 ...

证券代码：000516 证券简称：国际医学 公告编号：2025-040 股东名称 是否为控股股东 或第一大股东及 其一致行动人 本次解除质押 股份数量（股） 占其所持 股份比例 占公司总 股本比例 起始日 解除 日期 质权人 世纪新元 是 38,230,000 6.21% 1.71% 2022 年 8 月 30 日 2025 年 9 月 1 日 开源证券股份有限 公司 一、控股股东本次股份解除质押的基本情况 三、控股股东及其一致行动人股份累计质押的基本情况 截至公告披露日，世纪新元及其一致行动人所持质押股份情况如下： | | | | 本次质 | 本次质 | | | 已质押股份 | | 未质押股份 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | 押前质 | 押后质 | 占其 | 占公 | 情况 | | 情况 | | | 股东 | 持股数量 | 持股 | 押股份 | 押股份 | 所持 | 司总 | 已质押股 | 占已 | 未质押股 | 占未 | | 名称 | （股） | 比例 | 数量 | 数量 | 股 ...

Core Viewpoint - The company has experienced a decline in revenue and net profit in the first half of 2025, but has shown improvements in operational efficiency and service volume, indicating potential for recovery in the second half of the year [1][2][5]. Company Performance - In the first half of 2025, the company achieved operating revenue of 203,430.77 million yuan, a year-on-year decrease of 15.95% [2]. - The net profit attributable to shareholders was -16,496.18 million yuan, a year-on-year reduction in losses of 4.98% [2]. - The overall emergency and outpatient service volume reached 1.3191 million visits, an increase of 5.42% year-on-year [2]. - The net cash flow from operating activities was 59,254.20 million yuan, a year-on-year increase of 12.75% [2]. Hospital Operations - Xi'an Gaoxin Hospital reported emergency and outpatient visits of 578,700, a year-on-year increase of 3.04%, but inpatient visits decreased by 6.48% [3]. - Xi'an International Medical Center Hospital had emergency and outpatient visits of 740,500, a year-on-year increase of 7.37%, while inpatient visits decreased by 2.80% [3]. - Revenue for Xi'an International Medical Center Hospital was 138,327.49 million yuan, a year-on-year decrease of 15.37%, with a net profit of -11,320.98 million yuan, a decline of 44.63% [3]. Strategic Initiatives - The company is focusing on cost control through bed integration and departmental optimization, increasing the use of centralized procurement drugs and those meeting DRG payment standards [4]. - The company is developing specialty services such as health management, aesthetic medicine, physical examinations, elderly care, and international cooperation [4]. - Research in stem cells includes over 500 testing projects, with significant progress in clinical trials for mesenchymal stem cell treatments [4]. Future Outlook - For the second half of 2025, the company aims to maintain steady operations, enhance cost control, and improve efficiency while focusing on medical quality and patient service [6]. - The company plans to implement differentiated strategies to enhance added value and adapt to industry changes for orderly service expansion and improved profitability [6].

Group 1 - The company emphasizes enhancing intrinsic value and investor returns as its core objective [1] - Recently, the company has disclosed a "Market Value Management System" to improve operational management and drive high-quality development [1] - The company is the controlling shareholder of Xi'an Hancheng Lake Tourism Development Co., Ltd., holding 65% of its shares [1]